Multicenter study on pressure ulcers in hospice patients: prevalence, incidence and associated factors
Project objectivesThe main aim of the project is to characterize the pharmacokinetics and cardiotoxic bioactivation of pixantrone in translational models of human heart exposed to doxorubicin, with the aim of interpreting the clinical cardiotolerability of pixantrone in patients with non-Hodgkin's lymphoma and previous treatments containing doxorubicin. |
Start and end date |
| March 2010 - 2013 |
Project Manager |
| Prof. Girogio Minotti, Head of Pharmaceutical Sciences UR, Università Campus Bio-Medico di Roma and Fondazione Policlinico Universitario Campus Bio-Medico, Rome - Principal Investigator prof Emanuela Salvatorelli, UR Pharmaceutical Sciences, Campus Bio-Medico University, Rome - Co-Principal Investigator Prof. Pierantonio Menna, UR Clinical Pharmacology, Department of Science and Technology for Sustainable Development and One Health, Università Campus Bio-Medico di Roma; Campus Bio-Medico University Polyclinic Foundation - Co-Principal Investigator |
Coordinating institution of the project |
| UR Pharmaceutical Sciences, Departmental Faculty of Medicine and Surgery, Integrated Research Center, Campus Bio-Medico University, Rome |
Funding source(s). |
| • Cell Therapeutics Inc., Seattle, WA |
